Literature DB >> 6492167

Accumulation of rare and moderately abundant mRNAs in mouse L-cells is mainly post-transcriptionally regulated.

M Carneiro, U Schibler.   

Abstract

We have isolated ten complementary DNA recombinant plasmids, five for moderately abundant and five for rare L-cell mRNAs. The plasmids pLc1 to pLc5 contain inserts homologous to mRNAs that accumulate 220 to 640 copies per L-cell, while the plasmids pLc6 to pLc10 are complementary to rare mRNAs that accumulate 5 to 76 copies per L-cell. The cDNA plasmids pLc1 to pLc10 hybridize to cytoplasmic polyadenylated RNAs from several tissues. Thus it appears likely that the ten investigated mRNAs are coding for "housekeeping" functions. The relative transcription rates of the genes Lc1 to Lc10 were estimated by run-off transcription experiments in isolated L-cell nuclei. The results indicate that the transcription rates of genes that specify the moderately abundant mRNAs, Lc1 to Lc5, are not significantly higher than the genes specifying the rare mRNAs, Lc6 to Lc10. Thus the steady-state concentrations of the ten mRNAs investigated are modulated mainly at the post-transcriptional level. Kinetic labelling experiments confirm this conclusion and indicate that differential mRNA stability in the cytoplasm is largely responsible for the variation in accumulation of Lc1 to Lc10 mRNAs. Since housekeeping genes comprise the large majority of active genes, post-transcriptional regulation may well be the prevalent control in eucaryotic cells to determine the individual mRNA levels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6492167     DOI: 10.1016/0022-2836(84)90316-4

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  29 in total

1.  Intranuclear degradation of nonsense codon-containing mRNA.

Authors:  Marc Bühler; Miles F Wilkinson; Oliver Mühlemann
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

2.  Analysis of herpes simplex virus-induced mRNA destabilizing activity using an in vitro mRNA decay system.

Authors:  C M Sorenson; P A Hart; J Ross
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

3.  Transcriptional and posttranscriptional regulation of seed storage-protein gene expression in pea (Pisum sativum L.).

Authors:  A J Thompson; I M Evans; D Boulter; R R Croy; J A Gatehouse
Journal:  Planta       Date:  1989-10       Impact factor: 4.116

4.  Relative rates of RNA synthesis across the genome of Epstein-Barr virus are highest near oriP and oriLyt.

Authors:  S Metzenberg
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

5.  Transcriptional and posttranscriptional control of immunoglobulin mRNA production during B lymphocyte development.

Authors:  D E Kelley; R P Perry
Journal:  Nucleic Acids Res       Date:  1986-07-11       Impact factor: 16.971

6.  Characterization of DNA polymerase beta mRNA: cell-cycle and growth response in cultured human cells.

Authors:  B Z Zmudzka; A Fornace; J Collins; S H Wilson
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

7.  Histone mRNA degradation in vivo: the first detectable step occurs at or near the 3' terminus.

Authors:  J Ross; S W Peltz; G Kobs; G Brewer
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

8.  Abundance and half-life of the distinct oat phytochrome A3 and A4 mRNAs.

Authors:  D C Higgs; L J Barnes; J T Colbert
Journal:  Plant Mol Biol       Date:  1995-10       Impact factor: 4.076

9.  A potential role for RNA turnover in the light regulation of plant gene expression: ribulose-1,5-bisphosphate carboxylase small subunit in soybean.

Authors:  B W Shirley; R B Meagher
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

10.  Mammalian pre-mRNA 3' end processing factor CF I m 68 functions in mRNA export.

Authors:  Marc-David Ruepp; Chiara Aringhieri; Silvia Vivarelli; Stefano Cardinale; Simona Paro; Daniel Schümperli; Silvia M L Barabino
Journal:  Mol Biol Cell       Date:  2009-12       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.